eNOfit Portable Inhaled Nitric Oxide Delivery System
Respiratory failure / Pulmonary Hypertension (assumed, based on iNO use)
Key Facts
About Third Pole Therapeutics
Third Pole Therapeutics is pioneering a tankless, portable platform for generating inhaled nitric oxide (iNO), a critical therapy for pulmonary hypertension and other respiratory conditions. The company's lead investigational device, eNOfit, is designed as a wearable system, representing a significant departure from the current standard of large, stationary gas cylinders. With foundational technology from Harvard/MGH and recent successful feasibility studies, Third Pole is advancing toward clinical trials and potential commercialization. The company is privately held, backed by strategic equity investments, and targets a substantial market opportunity in both hospital and ambulatory settings.
View full company profile